Farmacología
Departamento
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Universitat de Barcelona (51)
2024
-
Exploring the reactivity of bicyclic α-iminophosphonates to access new imidazoline I2 receptor ligands
Bioorganic Chemistry, Vol. 142
-
The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls
EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783
2023
-
Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism
Neuropsychopharmacology, Vol. 48, Núm. 2, pp. 341-350
-
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease
Pharmaceutics, Vol. 15, Núm. 10
-
Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43
Neuropharmacology, Vol. 240
2022
-
Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome
eLife, Vol. 11
-
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
International Journal of Neuropsychopharmacology, Vol. 25, Núm. 6, pp. 468-478
-
Inhaled Loxapine as a Rapid Treatment for Agitation in Patients with Personality Disorder: A Prospective Study on the Effects of Time
Clinical Psychopharmacology and Neuroscience, Vol. 20, Núm. 3, pp. 482-490
-
NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
International Journal of Molecular Sciences, Vol. 23, Núm. 13
2021
-
Adrenergic Modulation With Photochromic Ligands
Angewandte Chemie - International Edition, Vol. 60, Núm. 7, pp. 3625-3631
-
Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 222
-
Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia
Neuropsychopharmacology, Vol. 46, Núm. 3, pp. 665-672
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Identification of bip as a cb1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain
Journal of Neuroscience, Vol. 41, Núm. 38, pp. 7924-7941
2020
-
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's Disease
Journal of Medicinal Chemistry, Vol. 63, Núm. 7, pp. 3610-3633
-
Calcium-binding proteins are altered in the cerebellum in schizophrenia
PloS one, Vol. 15, Núm. 7, pp. e0230400
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
Behavioral and Cognitive Improvement Induced by Novel Imidazoline I2 Receptor Ligands in Female SAMP8 Mice
Neurotherapeutics, Vol. 16, Núm. 2, pp. 416-431
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America